إعلان
إعلان
ACAD
Acadia Pharmaceuticals Inc.
26.30
USDبرعاية
-0.41
-1.54%
٠٢ يناير, ١٥:٥٦ UTC -5
مغلق
بعد الإغلاق
26.54
+0.23
+0.89%
تقارير أرباح ACAD
النسبة الإيجابية المفاجئة
ACAD تفوق 26 من 40 آخر التقديرات.
65%
التقرير التالي
بيانات التقرير القادم
٢٤ فبراير ٢٠٢٦
Estimate for Q4 25 (Revenue/ EPS)
$299.10M
/$0.14
التغير الضمني من Q3 25 (Revenue/ EPS)
+7.35%
/-66.67%
التغير الضمني من Q4 24 (Revenue/ EPS)
+15.22%
/-800.00%
Acadia Pharmaceuticals Inc. earnings per share and revenue
On ٠٥ نوفمبر ٢٠٢٥, ACAD reported earnings of 0.42 USD per share (EPS) for Q3 25, beating the estimate of 0.15 USD, resulting in a 178.15% surprise. Revenue reached 278.63 مليون, compared to an expected 282.00 مليون, with a -1.19% difference. The market reacted with a -3.05% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 22 analysts forecast an EPS of 0.14 USD, with revenue projected to reach 299.10 مليون USD, implying an decrease of -66.67% EPS, and increase of 7.35% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
enGene Holdings Inc. Common Stock
Report Date
٢٢ ديسمبر ٢٠٢٥ For ربع سنوي4 25
Estimate
-$0.57
الفعلي
-$0.73
مفاجئة
-25.95%
Outlook Therapeutics, Inc. Common Stock
Report Date
١٩ ديسمبر ٢٠٢٥ For ربع سنوي4 25
Estimate
-$0.25
الفعلي
-$0.19
مفاجئة
+26.47%
Citius Oncology, Inc. Common Stock
Report Date
٢٣ ديسمبر ٢٠٢٥ For ربع سنوي4 25
Estimate
-$0.12
الفعلي
-$0.06
مفاجئة
+50.98%
الأسئلة الشائعة
What were Acadia Pharmaceuticals Inc.'s earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Acadia Pharmaceuticals Inc. reported EPS of $0.42, beating estimates by 178.15%, and revenue of $278.63M, -1.19% below expectations.
How did the market react to Acadia Pharmaceuticals Inc.'s Q3 2025 earnings?
The stock price moved down -3.05%, changed from $22.33 before the earnings release to $21.65 the day after.
When is Acadia Pharmaceuticals Inc. expected to report next?
The next earning report is scheduled for ٢٤ فبراير ٢٠٢٦.
What are the forecasts for Acadia Pharmaceuticals Inc.'s next earnings report?
Based on 22
analysts, Acadia Pharmaceuticals Inc. is expected to report EPS of $0.14 and revenue of $299.10M for Q4 2025.
Which companies are reporting earnings today?
شيك FXEmpire's Earnings Calendar for today's list of reporting companies.
إعلان